Antidepressant efficacy is correlated with plasma levels: mega-analysis and further evidence

Venlafaxine and O-desmethylvenlafaxine serum levels are positively associated with antidepressant response in elder depressed out-patients

(2021) Domenico De Donatis et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

An Empirical Comparison of Meta- and Mega-Analysis With Data From the ENIGMA Obsessive-Compulsive Disorder Working Group

(2019) Premika S. W. Boedhoe et al.   Frontiers in Neuroinformatics

Duloxetine plasma level and antidepressant response

(2019) Domenico De Donatis et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Analysis of time-course, dose-effect, and influencing factors of antidepressants in the treatment of acute adult patients with major depression

(2019) Qingqing Cheng et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: Meta-analysis of data from genome-wide association studies

(2018) Chiara Fabbri et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017

(2018) C. Hiemke et al.   PHARMACOPSYCHIATRY

TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians

(2018) Georgios Schoretsanitis et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Escitalopram plasma levels and antidepressant response

(2017) Vincenzo Florio et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Systematic Review and Meta-Analysis: Dose-Response Relationship of Selective Serotonin Reuptake Inhibitors in Major Depressive Disorder

(2016) Ewgeni Jakubovski et al.   AMERICAN JOURNAL OF PSYCHIATRY

A mega-analysis of fixed-dose trials reveals dose-dependency and a rapid onset of action for the antidepressant effect of three selective serotonin reuptake inhibitors

(2016) F Hieronymus et al.   Translational Psychiatry

Application of cross-species PET imaging to assess neurotransmitter release in brain

(2015) Sjoerd J. Finnema et al.   PSYCHOPHARMACOLOGY

Therapeutic Drug Monitoring (TDM) in Psychiatry (Part I)

(2014) SHELDON H. PRESKORN   Journal of Psychiatric Practice

Early Improvement and Serum Concentrations of Citalopram to Predict Antidepressant Drug Response of Patients with Major Depression

(2013) E. Ostad Haji et al.   PHARMACOPSYCHIATRY

Therapeutic Drug Monitoring for Antidepressant Drug Treatment

(2012) Elnaz Ostad Haji et al.   CURRENT PHARMACEUTICAL DESIGN

Early antidepressant efficacy modulation by glutamatergic gene variants in the STAR⁎D

(2012) Chiara Fabbri et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Association Between Citalopram Serum Levels and Clinical Improvement of Patients With Major Depression

(2011) Elnaz Ostad Haji et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

[11C]Mirtazapine binding in depressed antidepressant nonresponders studied by PET neuroimaging

(2009) Donald F. Smith et al.   PSYCHOPHARMACOLOGY

Serum Concentrations of Antidepressant Drugs in a Naturalistic Setting: Compilation Based on a Large Therapeutic Drug Monitoring Database

(2009) Margareta Reis et al.   THERAPEUTIC DRUG MONITORING

The Influence of Smoking on the Serum Level of Duloxetine

(2008) M. Fric et al.   PHARMACOPSYCHIATRY